Clinical Trial Update: Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder [Phase 1]

View source ↗

Summary

Clinical Trial Update describing a Phase 1 study evaluating neuropharmacologic imaging and biomarker assessments of response to acute- and repeated-dose ketamin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Healthy Volunteer, Major Depressive Disorder | Phase 1 | Status: RECRUITING